Preventing pancreatitis after endoscopic bile duct procedures
Part of Digestive system clinical trials.
This study tests whether combining a rectal anti-inflammatory medication (indomethacin) with cold water cooling of the pancreas opening during an endoscopic procedure can better prevent pancreatitis—a painful inflammation of the pancreas—compared to medication alone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You need a standard medical reason for having an ERCP (endoscopic procedure to treat bile duct or pancreas issues)
- You cannot be pregnant or breastfeeding
- You cannot have chronic pancreatitis, pancreatic cancer, or acute pancreatitis in the past 2 weeks
- You cannot have severe kidney disease or active kidney injury
- You cannot have a history of rectal abnormalities or active bleeding problems
- You cannot be allergic to NSAIDs (anti-inflammatory drugs) or have severe liver disease
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether adding ice water irrigation to standard rectal indomethacin reduces the risk of inflammation of the pancreas after ERCP, a procedure that examines the bile and pancreatic ducts. It may help prevent a painful complication.
This trial tests whether rinsing the pancreas with cold water during ERCP can reduce the risk of pancreatitis, a common complication. The treatment is added to the standard medicine (indomethacin) to see if it offers extra protection.
This study tests whether a rectal dose of indomethacin (an anti-inflammatory drug) can help prevent complications after an ERCP. It is for people who have already had a sphincterotomy and are having another ERCP to treat bile duct issues.
This Phase 3 study tests whether putting an anti-inflammatory medicine into the rectum (indomethacin) plus taking an immune-suppressing pill (tacrolimus) works better than using the two medicines in a different combination to prevent pancreatitis after an ERCP procedure. If you qualify, you may be assigned to one of the treatment options to lower your risk of post-ERCP pancreas inflammation.
This trial tests whether giving an anti-inflammatory drug (diclofenac) before an ERCP procedure can help prevent a common complication called pancreatitis (inflammation of the pancreas). If you are scheduled for ERCP, you may be able to participate.
This study compares indomethacin (an anti-inflammatory medicine) against using a temporary pancreatic stent to prevent pancreatitis after an ERCP procedure. It may help you lower the chance of painful inflammation of the pancreas after ERCP.
Hear when a new Pancreas Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.